A quest to drug RNA
Matthew Disney’s research using small molecules that target RNA is featured in a story in The Scientist.
All Posts by
Matthew Disney’s research using small molecules that target RNA is featured in a story in The Scientist.
Jonathan D. Licht, M.D., was elected editor-in-chief of Blood Neoplasia after a competitive international search.
Jonathan Chatzkel, M.D., received the Positive Impact Award from the UF adult hematology and oncology fellows.
The projects reflect the center’s multidisciplinary, collaborative approach to cancer research.
Rachel Newsome's research focuses on host-microbe interactions regarding inflammation, cancer and cancer therapeutics.
The study suggests that colibactin may exacerbate mutations associated with colorectal cancer.
The grant funds a study of strategies to restore the function of aging blood vessels and stem cells.
Bently Doonan, M.D., was interviewed by WMFE/WMFV about the increasing incidence of early-onset cancer.
The long-term goal of the study is to develop a therapy to target treatment-refractory breast cancers.
Researchers led by Olga Guryanova, Ph.D., have discovered how age-related changes in the blood system can make certain colon cancers grow faster.